Novavax Inc. said Friday Chief Financial Officer Barclay Phillips has resigned to pursue and “expanded opportunity” in the industry. Phillips will step down, effective Nov. 10. Chief Executive Stanley Erck will act as interim CFO until a replacement can be found. The biotechnology company’s stock, which was still inactive in premarket trade, has gained 0.9% over the past three months, while the iShares Nasdaq Biotechnology ETF has climbed 6.6% and the S&P 500 has advanced 4.2%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News